CoChat

Short-term effects of semaglutide among patients with obesity with and without food addiction: an observational study

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Introduction Food addiction (FA) is highly prevalent among people with obesity (PwO) and may constitute a key factor in weight loss failure or weight regain. GLP-1 analogues have been shown to act on the mesolimbic system, which is related to hedonic overeating and substance abuse. We aimed to study the effects of low doses of semaglutide on FA symptomatology and to evaluate whether the presence of FA have a negative impact on weight loss despite treatment with semaglutide. Methods One hundred and thirteen PwO (45.5 ± 10.2 years) were evaluated anthropometrically baseline and after four months of treatment with semaglutide. PwO were evaluated for the presence of FA by completing The Spanish version of the Yale Food Addiction Scale 2.0 questionnaire (YFAS 2.0). Results Baseline BMI and fat mass (%) were greater among PwO with FA (35.8 ± 4.5 vs 33 ± 3.9 kg/m2and 44.2 ± 6.5 vs 40.1 ± 7.9%; p = .01). After four months of treatment with semaglutide, the prevalence of FA diminished from 57.5% to 4.2% (p < .001). The percentage of weight loss (6.9 ± 12.7 vs 5.3 ± 4.6%; p = .4) and the proportion of fat mass loss (2 ± 9 vs 1.6 ± 3.1%; p = .7) were comparable between PwO with and without FA. No differences regarding side effects and treatment discontinuations were seen between the two groups Conclusion Semaglutide is an effective tool for the amelioration of FA symptomatology among PwO. Despite PwO with FA had greater basal BMI and fat mass, semaglutide showed similar results compared…

Overview

Integrity signals

Registry

Crossref · 10.1080/10550887.2024.2315365

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 31 references

Cited by

See all 14

Metadata

Authors
Nicolau, J., Tamayo, M. I., Sanchís, P., Pujol, A., Pérez-Bec, G., Sfondrini, G., & Masmiquel, L.
Affiliations
Hospital Son Llatzer (ES)
Corresponding author
Nicolau, Joana
Venue
Journal of Addictive Diseases
Published
2024-02-18
Volume
42
Issue
4
Pages
535-543
ISSN
  • 1055-0887 (ISSN-L)
  • 1545-0848
OpenAlex
W4391921626
Cited by
14
References
31
Citations by year
2026: 1 · 2025: 9 · 2024: 4
FWCI
3.96
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Addictive Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
semaglutide, food addiction, obesity, GLP-1 receptor agonists, weight loss, fat loss, Yale Food Addiction Scale, mesolimbic system, weight regain
MeSH terms
Food Addiction, Semaglutide, Adult, Glucagon-Like Peptides, Female, Humans, Male, Middle Aged, Obesity, Weight Loss, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short-term effects of semaglutide among patients with obesity with and without food addiction: an observational study. https://app.cochat.ai/papers/10.1080/10550887.2024.2315365
The paper
Nicolau, J., Tamayo, M. I., Sanchís, P., Pujol, A., Pérez-Bec, G., Sfondrini, G., & Masmiquel, L. (2024). Short-term effects of semaglutide among patients with obesity with and without food addiction: an observational study. Journal of Addictive Diseases. https://doi.org/10.1080/10550887.2024.2315365

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.